SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues
2020
This second International Alliance for Biological Standardization COVID-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable participation from low- and middle-income countries, to discuss the use of controlled human infection models to accelerate development and market authorization assessment of a vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
6
Citations
NaN
KQI